Latest News
LENSAR, Inc.
- People to Know in Healthcare: Nick Curtis, Lensar
- Wall Street Zen downgrades LENSAR stock from Buy to Hold
- LENSAR Inc. (LNSR) Slips 0.30% to $6.57, Holding Above $6.24 Support - Value Area High
- Lucid Capital Markets initiates Lensar stock with buy rating By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →